Compound Radar

CVS Health Corporation (CVS) Stock Analysis

United States · Healthcare / Healthcare Plans

Price $96.07
Market cap $122.87B
Next earnings Oct 28, 2026
Entry status Watch $83.16–$88.30

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

51
51/100 Speculative
  • Financial Health 55
  • Profitability 45
  • Business Quality 65
  • Balance Sheet 40
  • Cash Flow 45

Why this rating?

Health 51/100 — Speculative

Strongest Business Quality 65/100
Softest Balance Sheet 40/100
Watch

Worth tracking, but timing is mixed — not a clear setup yet.

Company overview

CVS Health Corporation (CVS) is a Healthcare Plans company in the Healthcare sector. Compound Radar rates CVS Health Corporation 51/100 (Speculative) due to solid business quality, steady revenue growth, and elevated leverage.

Investment profile

  • Quality Moderate
  • Growth Moderate
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 25.35
  • Forward P/E 11.29
  • PEG 0.23
  • EV/Revenue 0.45

Profitability

  • Revenue Growth 7.1%
  • Gross Margin 13.6%
  • Operating Margin 3.9%
  • Net Margin 1.2%
  • ROE 6.2%

Financial strength

  • Cash $13.96B
  • Debt $76.31B
  • Net Cash $-62.35B
  • Free Cash Flow $7.81B
  • Current Ratio 0.87

Similar companies

Peers in Healthcare Plans, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Healthcare Plans →

FAQ

How Compound Radar scores and tracks CVS Health Corporation (CVS).

View Methodology & FAQ →